Opthea Ltd Appoints Sujal Shah to Board of Directors
Ticker: OPTEY · Form: 6-K · Filed: Apr 4, 2024 · CIK: 1815620
Sentiment: neutral
Topics: board-appointment, management
TL;DR
Opthea adds pharma vet Sujal Shah to its board, signaling potential strategic shifts.
AI Summary
Opthea Limited announced on April 4, 2024, the appointment of Sujal Shah as a new member of its Board of Directors. Shah brings extensive experience in the biopharmaceutical industry, having previously served as CEO of Denali Therapeutics. This appointment is effective immediately.
Why It Matters
The addition of Sujal Shah, a seasoned biopharmaceutical executive, to Opthea's board could bring valuable strategic guidance and industry connections, potentially impacting the company's future development and commercialization efforts.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a board appointment and does not contain significant financial or operational news that would immediately impact the company's risk profile.
Key Players & Entities
- Opthea Limited (company) — Registrant
- Sujal Shah (person) — Appointed to Board of Directors
- Denali Therapeutics (company) — Previous employer of Sujal Shah
- April 4, 2024 (date) — Filing date and announcement date
FAQ
Who is Sujal Shah and what is his relevant experience?
Sujal Shah has been appointed to Opthea's Board of Directors. He previously served as the CEO of Denali Therapeutics and has extensive experience in the biopharmaceutical industry.
When was this appointment announced?
The announcement was made on April 4, 2024, as indicated by the filing date.
What is the significance of this filing?
This is a Form 6-K filing, reporting the appointment of a new director to the company's Board of Directors.
What is Opthea Limited's primary business?
Opthea Limited is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
Where is Opthea Limited headquartered?
Opthea Limited is headquartered in South Yarra, Victoria, Australia.
Filing Stats: 150 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-04-03 17:38:05
Filing Documents
- opt_board_appointment.htm (6-K) — 22KB
- opt-ex99_1.htm (EX-99.1) — 34KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-041337.txt ( ) — 225KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 04/04/2024